Posted inBiotechnology
Amgen dances with Disco in $618M cancer target pact
Amgen is getting down with Disco Pharmaceuticals, commissioning the German outfit to work on cancer therapies focused on a target…
Posted inBiotechnology
Rakuten lights path to 2028 FDA filing with fresh $100M raise
Rakuten Medical has added to its tally of megarounds, pocketing another $100 million to push its lead light-based cancer therapy toward…
Posted inBiotechnology
Soley secures $200M series C to push AML cell stress drug into clinic
Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its…
Posted inBiotechnology
Decadal Observations Reveal Plant Diversity Stabilizes Ecosystems
In the quest to unravel the complexities of ecosystem stability, a recent groundbreaking study has illuminated the profound impact of…
Posted inBiotechnology
Chromatin Dynamics in Plasmodium falciparum Life Cycle
The intricate world of malaria parasites, particularly Plasmodium falciparum, continues to reveal its mysteries through ongoing scientific advancements. Recently, a…
![catalytic-enantioselective-[1,2]-wittig-rearrangement-breakthrough](https://biotechgrid.com/wp-content/uploads/2026/01/24378-catalytic-enantioselective-12-wittig-rearrangement-breakthrough.jpg)
Posted inBiotechnology
Catalytic Enantioselective [1,2]-Wittig Rearrangement Breakthrough
In a groundbreaking development poised to reshape synthetic organic chemistry, researchers have unveiled a novel catalytic cascade that achieves an…
Posted inBiotechnology
Silibinin-Dendrimer Au Nanoparticles Combat Vancomycin Resistance
In an innovative stride toward combating antibiotic resistance, a groundbreaking study has emerged from a collaborative effort led by researchers…
Posted inBiotechnology
Sweet Potato Leaf Silage Boosts Growth in Pigs
In an innovative study published in the journal “Discover Animals,” researchers have explored the potential of sweet potato leaf silage…
Posted inBiotechnology
Basilea pens collab with US biotech to develop new antifungal
Basilea Pharmaceutica is continuing its quest to develop much-needed new antifungal drugs by penning a deal with Prokaryotics. The collaboration…
Posted inBiotechnology
GSK’s ‘functional cure’ for hep B proves worth in phase 3 trials setting up approval push
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3…